{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:08:38Z","timestamp":1788390518913,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"DOI":"10.7759\/cureus.41893","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T19:18:57Z","timestamp":1689362337000},"source":"Crossref","is-referenced-by-count":1,"title":["Addressing Barriers to Care in Hepatocellular Carcinoma: Promoting Equity and Access"],"prefix":"10.7759","author":[{"given":"Sindhu","family":"Vikash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Vikash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarushi","family":"Sudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat","family":"Adal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i18.2127","article-title":"Three decades of hepatitis B control with vaccination","volume":"7","author":"Meireles LC","year":"2015","unstructured":"Meireles LC, Marinho RT, Van Damme P. Three decades of hepatitis B control with vaccination. World J Hepatol. 2015, 7:2127-32. 10.4254\/wjh.v7.i18.2127","journal-title":"World J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag HB","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012, 142:1264-1273. 10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005","volume":"43","author":"Yim HJ","year":"2006","unstructured":"Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006, 43:173-81. 10.1002\/hep.20956","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al.. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67:1560-99. 10.1002\/hep.29800","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States","volume":"52","author":"Davila JA","year":"2010","unstructured":"Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010, 52:132-41. 10.1002\/hep.23615","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1952-x","article-title":"Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review","volume":"27","author":"Singal AG","year":"2012","unstructured":"Singal AG, Yopp A, S Skinner C, Packer M, Lee WM, Tiro JA. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med. 2012, 27:861-7. 10.1007\/s11606-011-1952-x","journal-title":"J Gen Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000001825","article-title":"Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019","volume":"61","author":"Pham TT","year":"2023","unstructured":"Pham TT, Toy M, Hutton D, et al.. Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019. Med Care. 2023, 61:247-53. 10.1097\/MLR.0000000000001825","journal-title":"Med Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01401.x","article-title":"Is chronic hepatitis B being undertreated in the United States?","volume":"18","author":"Cohen C","year":"2011","unstructured":"Cohen C, Holmberg SD, McMahon BJ, et al.. Is chronic hepatitis B being undertreated in the United States?. J Viral Hepat. 2011, 18:377-83. 10.1111\/j.1365-2893.2010.01401.x","journal-title":"J Viral Hepat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00304.x","article-title":"World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants","volume":"9","author":"Funk ML","year":"2002","unstructured":"Funk ML, Rosenberg DM, Lok AS. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat. 2002, 9:52-61. 10.1046\/j.1365-2893.2002.00304.x","journal-title":"J Viral Hepat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7644","article-title":"HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection","volume":"20","author":"Alexopoulou A","year":"2014","unstructured":"Alexopoulou A, Karayiannis P. HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. World J Gastroenterol. 2014, 20:7644-52. 10.3748\/wjg.v20.i24.7644","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90632-b","article-title":"Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region","volume":"99","author":"Akahane Y","year":"1990","unstructured":"Akahane Y, Yamanaka T, Suzuki H, et al.. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology. 1990, 99:1113-9. 10.1016\/0016-5085(90)90632-b","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001530","article-title":"Low rates of hepatitis B virus treatment among treatment-eligible patients in safety-net health systems","volume":"56","author":"Wong RJ","year":"2022","unstructured":"Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M. Low rates of hepatitis B virus treatment among treatment-eligible patients in safety-net health systems. J Clin Gastroenterol. 2022, 56:360-8. 10.1097\/MCG.0000000000001530","journal-title":"J Clin Gastroenterol"},{"key":"ref13","unstructured":"Blue Cross Medicare Advantage Flex (PPO). (2022). Accessed. November 16, 2022: https:\/\/www.bcbsil.com\/medicare\/pdf\/2022\/mapd-formulary-ppo-flex-il-2022.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Singal AG","year":"2014","unstructured":"Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014, 11:10.1371\/journal.pmed.1001624","journal-title":"PLoS Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-018-00604-7","article-title":"Barriers to disease monitoring and liver cancer surveillance among patients with chronic hepatitis B in the United States","volume":"44","author":"Ispas S","year":"2019","unstructured":"Ispas S, So S, Toy M. Barriers to disease monitoring and liver cancer surveillance among patients with chronic hepatitis B in the United States. J Community Health. 2019, 44:610-25. 10.1007\/s10900-018-00604-7","journal-title":"J Community Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i22.6914","article-title":"Medical training fails to prepare providers to care for patients with chronic hepatitis B infection","volume":"21","author":"Chao SD","year":"2015","unstructured":"Chao SD, Wang BM, Chang ET, Ma L, So SK. Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World J Gastroenterol. 2015, 21:6914-23. 10.3748\/wjg.v21.i22.6914","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000738","article-title":"Provider, patient, and practice factors shape hepatitis B prevention and management by primary care providers","volume":"51","author":"Mukhtar NA","year":"2017","unstructured":"Mukhtar NA, Kathpalia P, Hilton JF, et al.. Provider, patient, and practice factors shape hepatitis B prevention and management by primary care providers. J Clin Gastroenterol. 2017, 51:626-31. 10.1097\/MCG.0000000000000738","journal-title":"J Clin Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2870-z","article-title":"Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care","volume":"59","author":"Burman BE","year":"2014","unstructured":"Burman BE, Mukhtar NA, Toy BC, et al.. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care. Dig Dis Sci. 2014, 59:46-56. 10.1007\/s10620-013-2870-z","journal-title":"Dig Dis Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004744","article-title":"Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B","volume":"95","author":"Wang C","year":"2016","unstructured":"Wang C, Chen V, Vu V, et al.. Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine (Baltimore). 2016, 95:10.1097\/MD.0000000000004744","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29362","article-title":"Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers","volume":"66","author":"Konerman MA","year":"2017","unstructured":"Konerman MA, Thomson M, Gray K, Moore M, Choxi H, Seif E, Lok AS. Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers. Hepatology. 2017, 66:1805-13. 10.1002\/hep.29362","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154902-addressing-barriers-to-care-in-hepatocellular-carcinoma-promoting-equity-and-access","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:00Z","timestamp":1707509100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154902-addressing-barriers-to-care-in-hepatocellular-carcinoma-promoting-equity-and-access"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.41893","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}